美国 · SEC FORM 4
PROKIDNEY CORP.
PROK · Nasdaq · CIK 0001850270 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
6 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-04-22 · Control Empresarial de Capitales S.A. de C.V..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 23,785,320
- 上期报告
- 21,445,366
- 日均成交量
- 2,167,549
- 回补天数
- 11.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 387,393 | USD 0.71 | USD 275,049 | SEC 申报 ↗ |
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 25,000 | USD 0.75 | USD 18,750 | SEC 申报 ↗ |
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 100,000 | USD 0.75 | USD 75,000 | SEC 申报 ↗ |
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 468,000 | USD 0.70 | USD 327,600 | SEC 申报 ↗ |
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 268,105 | USD 0.73 | USD 195,717 | SEC 申报 ↗ |
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 1,900 | USD 0.61 | USD 1,159 | SEC 申报 ↗ |
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 1,032,218 | USD 0.61 | USD 629,653 | SEC 申报 ↗ |
| 2024-06-13 | Legorreta Pablo G.; Tolerantia, LLC | 买入 (P) | Class A Ordinary Shares | 22,617,909 | USD 2.42 | USD 54,735,340 | SEC 申报 ↗ |
| 2024-06-11 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 8,264,462 | USD 2.42 | USD 19,999,998 | SEC 申报 ↗ |
| 2024-03-25 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 30,000 | USD 1.43 | USD 42,900 | SEC 申报 ↗ |
| 2024-03-22 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 14,000 | USD 1.40 | USD 19,600 | SEC 申报 ↗ |
| 2024-03-20 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 33,000 | USD 1.40 | USD 46,200 | SEC 申报 ↗ |
| 2024-03-14 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 50,000 | USD 1.36 | USD 68,000 | SEC 申报 ↗ |
| 2024-03-13 | Control Empresarial de Capitales S.A. de C.V. | 买入 (P) | Class A Ordinary Shares (as defined in Exhibit 99.1 hereto) | 50,000 | USD 1.50 | USD 75,000 | SEC 申报 ↗ |
| 2022-09-06 | Cowen Aaron | 买入 (P) | Class A Ordinary Shares | 7,007 | USD 6.99 | USD 48,979 | SEC 申报 ↗ |
Form 4 申报证据
14 transaction lines in the latest 365-day window; 105 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 250,000 | USD 1.42 | USD 355,000 | SEC 申报 ↗ |
| 2026-08-19 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 250,000 | USD 1.44 | USD 360,000 | SEC 申报 ↗ |
| 2026-08-18 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 257,164 | USD 1.37 | USD 352,315 | SEC 申报 ↗ |
展开近期 Form 4 证据 (8 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 250,000 | USD 1.42 | USD 355,000 | SEC 申报 ↗ |
| 2026-08-19 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 250,000 | USD 1.44 | USD 360,000 | SEC 申报 ↗ |
| 2026-08-18 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 257,164 | USD 1.37 | USD 352,315 | SEC 申报 ↗ |
| 2026-08-04 | Pereira Brian JG | C (C) | Class A Common Stock | 757,164 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-12 | Girolamo Todd C | C (C) | Class A Common Stock | 163,857 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-28 | Control Empresarial de Capitales S.A. de C.V. | C (C) | Class A Common Shares (as defined in Exhibit 99.1 hereto) | 63,118,645 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-13 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 502,136 | USD 2.37 | USD 1,190,062 | SEC 申报 ↗ |
| 2025-11-12 | Pereira Brian JG | 卖出 (S) | Class A Common Stock | 255,026 | USD 2.72 | USD 693,671 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PROK |
| CIK | 0001850270 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 105 transaction lines from 2021-07-02 to 2026-08-20 18 P purchase lines · 56 S sale lines · 31 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.